DOCSLIB.ORG

Stress Dose Steroids: Myths and Perioperative Medicine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Stress Dose Steroids: Myths and Perioperative Medicine Stress Dose Steroids: Myths and Perioperative Medicine Literature Review by Sina Moshiri Introduction Many patients presenting for surgery receive regular doses of glucocorticoids for treatment of systemic autoimmune inflammatory disease, asthma and chronic pulmonary disease, and post organ transplantation Traditionally, supplemental dosing of glucocorticoids prior to surgery was thought to be necessary in these patients to avoid hypotension and shock Alternative strategies were rarely considered, and patients still often receive preoperative steroids despite the known infectious, metabolic and would healing risks associated with glucocorticoids Recommendations for perioperative glucocorticoid management have remained unchallenged despite the relative frequency with which many patients use glucocorticoids, and the little evidence supporting this practice Rationale behind this practice was based on the positive feedback inhibition governing the hypothalamic-pituitary-adrenal (HPA) axis. It was thought that long-term, iatrogenic glucocorticoid administration would result in suppression of the HPA axis and increase risk of adrenal crisis in response to surgical stress. This paper seeks to review the perioperative mechanism and use of glucocorticoids, and review the literature and recommendations on which these practices are based. Adrenal Physiology The body consists of two adrenal glands situated on top of the kidneys. These glands help maintain homeostasis through production of two hormones, cortisol (glucocorticoids) and aldosterone (mineralocorticoid). Adrenal glands are involved in electrolyte and fluid balance, which is regulated by a feedback mechanism. Release of corticotropin releasing hormone (CRH) from hypothalamus, stimulates the release of adrenocorticotropic (ACTH) from the pituitary gland. ACTH triggers the production of cortisol by the adrenal glands. Cortisol is released in response to stress and low blood sugar, and has various metabolic effects on the body. At normal conditions the body produces 10-12 mg cortisol per day. Serum levels consist of 18-20 ug/dl, 30-45 ug/dl, and as high as 260 ug/dl in mildly, moderately and life threatening levels of stress, respectively. Cortisol levels normalize within 24-48 hours of the stressful event. Glucocorticoid secretion increases in proportion to the degree of stress. Surgery is a potent stressor that triggers the HPA axis by raising ACTH levels. Levels of cortisol may remain elevated for up to 24-48 hours, and may increase by 5-10 times versus a baseline of 20-30 mg/day of hydrocortisone (5-7 mg/day of prednisone). Adrenal insufficiency (AI) occurs due to adrenal gland dysfunction or destruction, resulting in inadequate cortisol needed to maintain homeostasis Primary AI (Addison's disease) results from destruction of adrenal cortex and may be due to autoimmune disorders (HIV, CMV) tuberculosis, hemorrhage, tumor metastasis and sepsis. In the USA, 80% of primary AI results from autoimmune adrenalitis, and is often related to other autoimmune disorders such as Hashimoto's thyroiditis, Grave's disease, type I diabetes, premature ovarian failure, hypoparathyroidism and testicular failure Secondary and tertiary AI result from hypothalamic or pituitary absence or suppression Administration of exogenous glucocorticoids suppresses cortisol production through central inhibition of the hypothalamus. Mineralocorticoid production is usually unaffected since its production is regulated by the renin-angiotensin system. 5 mg prednisone (20 mg hydrocortisone) for ≥ 2 weeks has been shows to produce measurable changes to the HPA axis, with decreased cortisol release persisting up to a year after the end of glucocorticoid therapy. However the clinical significance of these findings is unclear and it remains to be seen which patients require supplemental dosing. The magnitude of adrenal suppression depends on numerous factors, including dose, duration, frequency and route of administration. Origins and Rationale of Stress Dosing First case reporting the surgical risks associated with previous long term glucocorticoid use involved a patient who died due to hypotension during orthopedic surgery (Fraser, 1952).The life threatening sequelae consisting of nausea, vomiting, hypoglycemia, hyponatremia, hyperkalemia, hypotension and shock was termed adrenal crisis. The demonstration of adrenal atrophy after autopsy and the severity of the adverse events drove the development of the concept of “stress dosing” – administration of steroids in perioperative and other stressful medical setting Systemic review by Marik and Varon examining the use of stress dosing found a lack of strong data and small sample size; only 315 patients comprise the patient base from which this practice is justified An RCT by Glowniak and Loriaux found no difference in the intra- and post-operative blood pressure in glucocorticoid dependent patients receiving either a stress dose or a placebo prior to surgery Thomason et al. (1999) performed a double-blind crossover study involving 20 organ transplant patients undergoing gingivectomy under local anesthesia. No significant differences in blood pressure and no adverse symptoms were noted in any patients. A Cochrane review of RCT examining stress dose steroids for surgical patients with adrenal insufficiency found the current evidence to be limited by a small sample size. The authors concluded the use of supplemental steroid dosing could neither be supported or refuted (Yong et al. 2009). The most extensive investigation of adrenal physiology during surgery in glucocorticoid dependent patients involved a cohort study with 41 patients with rheumatoid arthritis undergoing synovectomy of the knee. Half of the patients received oral steroids prior to surgery. All patients discontinued glucocorticoids 18 hours before surgery. HPA axis was thoroughly evaluated prior to, during and after surgery. In all cases, there were small yet clinically insignificant changes in blood pressure during the peri- and postoperative periods. One patient who had stopped glucocorticoids 48 hours prior to surgery developed hypotension during surgery which was managed successfully with hydrocortisone and fluids. Perioperative Steroid Management Based on the available, impactful evidence available the authors continue that traditional practice of supplemental glucocorticoids may result in unnecessary exposure to steroids, leading to hyperglycemia, hypertension, fluid retention and increased risk of infection. In particular, research indicates recent doses of glucocorticoids have the greatest impact on infection risk, with prednisone doses of >15mg/day identified as a risk factor for prosthetic joint infection. A more conservative approach to supplemental glucocorticoid dosing is indicated. The authors’ recommendations are summarized below: Stress dosing steroids due to a presumed adrenal insufficiency is unnecessary. Example in which stress dosing is not required include: 1) patients taking ≤ 10 mg/day of prednisone (or equivalent), 2) patients on alternative-day oral regimens, 3) patients using topical steroids. For these circumstances, the recommendation applies regardless on the type of surgery being performed. For all other instances, the recommendations are based on the exposure level, type and magnitude of surgery. When deemed appropriate (usually for large surgical procedures), dosage should be based on secretory rate of cortisol during anesthesia and major surgery. This production may range from 75-150 mg/day and a modest dosing paradigm may involve 50 mg hydrocortisone intraoperative q8h for 48-72 hours. Intravenous administration may be replaced by oral intake as soon as the patient can tolerate it. Contraindications to conservative management do exist. Conservative approach should not apply to patients with primary (Addison’s disease) adrenal failure, hypopituitarism, congenital adrenal hyperplasia or to glucocorticoid-dependent children. Ultimately, the treating physician must remain vigilant and must be ready to react to clinical emergencies with exogenous steroids. Should hypotension or other symptoms of adrenal crisis occur that cannot be attributed to other mechanism such as volume depletion, a supraphysiologic dose of steroids is warranted. Summary Supplemental steroid dosing in the context of surgery is a treatment paradigm that remains unchallenged despite the lack of convincing evidence. Spurred primarily by a few case reports and supported by a feasible pathophysiology, this practice has persisted for over 60 years. Due to the known risks of exogenous glucocorticoid therapy as well as modern evidence and clinical experience, this practice warrants reconsideration In order to establish evidence-based guidelines, additional randomized control trials and cohort studies are necessary to evaluate the risk of peri- and postoperative hemodynamic changes in glucocorticoid dependent patients undergoing surgery For now, the prudent practioner will continue providing supplemental steroid dose for the high risk patients (true adrenal insufficiency, extensive surgical procedure) and will practice a more conservative approach for low risk patients (minor surgery with local anesthesia, patients taking ≤ 10 mg prednisone per day) References MacKenzie, C. Ronald, and Susan M. Goodman. "Stress dose steroids: myths and perioperative medicine." Current rheumatology reports 18.7 (2016): 47. .
Load more

Recommended publications
  • This Fact Sheet Provides Information to Patients with Eczema and Their Carers. About Topical Corticosteroids How to Apply Topic
    This fact sheet provides information to patients with eczema and their carers. About topical corticosteroids You or your child’s doctor has prescribed a topical corticosteroid for the treatment of eczema. For treating eczema, corticosteroids are usually prepared in a cream or ointment and are applied topically (directly onto the skin). Topical corticosteroids work by reducing inflammation and helping to control an over-reactive response of the immune system at the site of eczema. They also tighten blood vessels, making less blood flow to the surface of the skin. Together, these effects help to manage the symptoms of eczema. There is a range of steroids that can be used to treat eczema, each with different strengths (potencies). On the next page, the potencies of some common steroids are shown, as well as the concentration that they are usually used in cream or ointment preparations. Using a moisturiser along with a steroid cream does not reduce the effect of the steroid. There are many misconceptions about the side effects of topical corticosteroids. However these treatments are very safe and patients are encouraged to follow the treatment regimen as advised by their doctor. How to apply topical corticosteroids How often should I apply? How much should I apply? Apply 1–2 times each day to the affected area Enough cream should be used so that the of skin according to your doctor’s instructions. entire affected area is covered. The cream can then be rubbed or massaged into the Once the steroid cream has been applied, inflamed skin. moisturisers can be used straight away if needed.
    [Show full text]
  • 4. Antibacterial/Steroid Combination Therapy in Infected Eczema
    Acta Derm Venereol 2008; Suppl 216: 28–34 4. Antibacterial/steroid combination therapy in infected eczema Anthony C. CHU Infection with Staphylococcus aureus is common in all present, the use of anti-staphylococcal agents with top- forms of eczema. Production of superantigens by S. aureus ical corticosteroids has been shown to produce greater increases skin inflammation in eczema; antibacterial clinical improvement than topical corticosteroids alone treatment is thus pivotal. Poor patient compliance is a (6, 7). These findings are in keeping with the demon- major cause of treatment failure; combination prepara- stration that S. aureus can be isolated from more than tions that contain an antibacterial and a topical steroid 90% of atopic eczema skin lesions (8); in one study, it and that work quickly can improve compliance and thus was isolated from 100% of lesional skin and 79% of treatment outcome. Fusidic acid has advantages over normal skin in patients with atopic eczema (9). other available topical antibacterial agents – neomycin, We observed similar rates of infection in a prospective gentamicin, clioquinol, chlortetracycline, and the anti- audit at the Hammersmith Hospital, in which all new fungal agent miconazole. The clinical efficacy, antibac- patients referred with atopic eczema were evaluated. In terial activity and cosmetic acceptability of fusidic acid/ a 2-month period, 30 patients were referred (22 children corticosteroid combinations are similar to or better than and 8 adults). The reason given by the primary health those of comparator combinations. Fusidic acid/steroid physician for referral in 29 was failure to respond to combinations work quickly with observable improvement prescribed treatment, and one patient was referred be- within the first week.
    [Show full text]
  • Salivary 17 Α-Hydroxyprogesterone Enzyme Immunoassay Kit
    SALIVARY 17 α-HYDROXYPROGESTERONE ENZYME IMMUNOASSAY KIT For Research Use Only Not for use in Diagnostic Procedures Item No. 1-2602, (Single) 96-Well Kit; 1-2602-5, (5-Pack) 480 Wells Page | 1 TABLE OF CONTENTS Intended Use ................................................................................................. 3 Introduction ................................................................................................... 3 Test Principle ................................................................................................. 4 Safety Precautions ......................................................................................... 4 General Kit Use Advice .................................................................................... 5 Storage ......................................................................................................... 5 pH Indicator .................................................................................................. 5 Specimen Collection ....................................................................................... 6 Sample Handling and Preparation ................................................................... 6 Materials Supplied with Single Kit .................................................................... 7 Materials Needed But Not Supplied .................................................................. 8 Reagent Preparation ....................................................................................... 9 Procedure ...................................................................................................
    [Show full text]
  • Cortisol Deficiency and Steroid Replacement Therapy
    Great Ormond Street Hospital for Children NHS Foundation Trust: Information for Families Cortisol deficiency and steroid replacement therapy This leaflet explains about cortisol deficiency and how it is treated. It also contains information about how to deal with illnesses, accidents and other stressful events in children on cortisol replacement. Where are the The two most important ones are: adrenal glands and • Aldosterone – this helps regulate what do they do? the blood pressure by controlling how much salt is retained in the The adrenal glands rest on the tops body. If a person is unable to of the kidneys. They are part of the make aldosterone themselves, they endocrine system, which organises the will need to take a tablet called release of hormones within the body. ‘fludrocortisone’. Hormones are chemical messengers that switch on and off processes within the • Cortisol – this is the body’s natural body. steroid and has three main functions: The adrenal glands consist of two parts: - helping to control the blood the medulla (inner section) which sugar level makes the hormone ‘adrenaline’ which is part of the ‘fight or flight’ - helping the body deal with stress response a person has when stressed. - helping to control blood pressure the cortex (outer section) which and blood circulation. releases several hormones. If a person is unable to make cortisol themselves, they will need to take a tablet to replace it. Pituitary gland The most common form used is hydrocortisone, but other forms Parathyroid gland may be prescribed. Thyroid gland Medulla Cortex Adrenal Thymus gland Gland Kidney Adrenal gland Pancreas Sheet 1 of 7 Ref: 2014F0715 © GOSH NHS Foundation Trust March 2015 What is In these circumstances, the amount cortisol deficiency? of hydrocortisone given needs to be increased quickly.
    [Show full text]
  • Steroid Use in Prednisone Allergy Abby Shuck, Pharmd Candidate
    Steroid Use in Prednisone Allergy Abby Shuck, PharmD candidate 2015 University of Findlay If a patient has an allergy to prednisone and methylprednisolone, what (if any) other corticosteroid can the patient use to avoid an allergic reaction? Corticosteroids very rarely cause allergic reactions in patients that receive them. Since corticosteroids are typically used to treat severe allergic reactions and anaphylaxis, it seems unlikely that these drugs could actually induce an allergic reaction of their own. However, between 0.5-5% of people have reported any sort of reaction to a corticosteroid that they have received.1 Corticosteroids can cause anything from minor skin irritations to full blown anaphylactic shock. Worsening of allergic symptoms during corticosteroid treatment may not always mean that the patient has failed treatment, although it may appear to be so.2,3 There are essentially four classes of corticosteroids: Class A, hydrocortisone-type, Class B, triamcinolone acetonide type, Class C, betamethasone type, and Class D, hydrocortisone-17-butyrate and clobetasone-17-butyrate type. Major* corticosteroids in Class A include cortisone, hydrocortisone, methylprednisolone, prednisolone, and prednisone. Major* corticosteroids in Class B include budesonide, fluocinolone, and triamcinolone. Major* corticosteroids in Class C include beclomethasone and dexamethasone. Finally, major* corticosteroids in Class D include betamethasone, fluticasone, and mometasone.4,5 Class D was later subdivided into Class D1 and D2 depending on the presence or 5,6 absence of a C16 methyl substitution and/or halogenation on C9 of the steroid B-ring. It is often hard to determine what exactly a patient is allergic to if they experience a reaction to a corticosteroid.
    [Show full text]
  • Etats Rapides
    List of European Pharmacopoeia Reference Standards Effective from 2015/12/24 Order Reference Standard Batch n° Quantity Sale Information Monograph Leaflet Storage Price Code per vial Unit Y0001756 Exemestane for system suitability 1 10 mg 1 2766 Yes +5°C ± 3°C 79 ! Y0001561 Abacavir sulfate 1 20 mg 1 2589 Yes +5°C ± 3°C 79 ! Y0001552 Abacavir for peak identification 1 10 mg 1 2589 Yes +5°C ± 3°C 79 ! Y0001551 Abacavir for system suitability 1 10 mg 1 2589 Yes +5°C ± 3°C 79 ! Y0000055 Acamprosate calcium - reference spectrum 1 n/a 1 1585 79 ! Y0000116 Acamprosate impurity A 1 50 mg 1 3-aminopropane-1-sulphonic acid 1585 Yes +5°C ± 3°C 79 ! Y0000500 Acarbose 3 100 mg 1 See leaflet ; Batch 2 is valid until 31 August 2015 2089 Yes +5°C ± 3°C 79 ! Y0000354 Acarbose for identification 1 10 mg 1 2089 Yes +5°C ± 3°C 79 ! Y0000427 Acarbose for peak identification 3 20 mg 1 Batch 2 is valid until 31 January 2015 2089 Yes +5°C ± 3°C 79 ! A0040000 Acebutolol hydrochloride 1 50 mg 1 0871 Yes +5°C ± 3°C 79 ! Y0000359 Acebutolol impurity B 2 10 mg 1 -[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino] propoxy]phenyl] 0871 Yes +5°C ± 3°C 79 ! acetamide (diacetolol) Y0000127 Acebutolol impurity C 1 20 mg 1 N-(3-acetyl-4-hydroxyphenyl)butanamide 0871 Yes +5°C ± 3°C 79 ! Y0000128 Acebutolol impurity I 2 0.004 mg 1 N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl] 0871 Yes +5°C ± 3°C 79 ! butanamide Y0000056 Aceclofenac - reference spectrum 1 n/a 1 1281 79 ! Y0000085 Aceclofenac impurity F 2 15 mg 1 benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate
    [Show full text]
  • St John's Institute of Dermatology
    St John’s Institute of Dermatology Topical steroids This leaflet explains more about topical steroids and how they are used to treat a variety of skin conditions. If you have any questions or concerns, please speak to a doctor or nurse caring for you. What are topical corticosteroids and how do they work? Topical corticosteroids are steroids that are applied onto the skin and are used to treat a variety of skin conditions. The type of steroid found in these medicines is similar to those produced naturally in the body and they work by reducing inflammation within the skin, making it less red and itchy. What are the different strengths of topical corticosteroids? Topical steroids come in a number of different strengths. It is therefore very important that you follow the advice of your doctor or specialist nurse and apply the correct strength of steroid to a given area of the body. The strengths of the most commonly prescribed topical steroids in the UK are listed in the table below. Table 1 - strengths of commonly prescribed topical steroids Strength Chemical name Common trade names Mild Hydrocortisone 0.5%, 1.0%, 2.5% Hydrocortisone Dioderm®, Efcortelan®, Mildison® Moderate Betamethasone valerate 0.025% Betnovate-RD® Clobetasone butyrate 0.05% Eumovate®, Clobavate® Fluocinolone acetonide 0.001% Synalar 1 in 4 dilution® Fluocortolone 0.25% Ultralanum Plain® Fludroxycortide 0.0125% Haelan® Tape Strong Betamethasone valerate 0.1% Betnovate® Diflucortolone valerate 0.1% Nerisone® Fluocinolone acetonide 0.025% Synalar® Fluticasone propionate 0.05% Cutivate® Hydrocortisone butyrate 0.1% Locoid® Mometasone furoate 0.1% Elocon® Very strong Clobetasol propionate 0.1% Dermovate®, Clarelux® Diflucortolone valerate 0.3% Nerisone Forte® 1 of 5 In adults, stronger steroids are generally used on the body and mild or moderate steroids are used on the face and skin folds (armpits, breast folds, groin and genitals).
    [Show full text]
  • Connecticut Medicaid
    ACNE AGENTS, TOPICAL ‡ ANGIOTENSIN MODULATOR COMBINATIONS ANTICONVULSANTS, CONT. CONNECTICUT MEDICAID (STEP THERAPY CATEGORY) AMLODIPINE / BENAZEPRIL (ORAL) LAMOTRIGINE CHEW DISPERS TAB (not ODT) (ORAL) (DX CODE REQUIRED - DIFFERIN, EPIDUO and RETIN-A) AMLODIPINE / OLMESARTAN (ORAL) LAMOTRIGINE TABLET (IR) (not ER) (ORAL) Preferred Drug List (PDL) ACNE MEDICATION LOTION (BENZOYL PEROXIDE) (TOPICAL)AMLODIPINE / VALSARTAN (ORAL) LEVETIRACETAM SOLUTION, IR TABLET (not ER) (ORAL) • The Connecticut Medicaid Preferred Drug List (PDL) is a BENZOYL PEROXIDE CREAM, WASH (not FOAM) (TOPICAL) OXCARBAZEPINE TABLET (ORAL) listing of prescription products selected by the BENZOYL PEROXIDE 5% and 10% GEL (OTC) (TOPICAL) ANTHELMINTICS PHENOBARBITAL ELIXIR, TABLET (ORAL) Pharmaceutical and Therapeutics Committee as efficacious, BENZOYL PEROXIDE 6% CLEANSER (OTC) (TOPICAL) ALBENDAZOLE TABLET (ORAL) PHENYTOIN CHEW TABLET, SUSPENSION (ORAL) safe and cost effective choices when prescribing for HUSKY CLINDAMYCIN PH 1% PLEGET (TOPICAL) BILTRICIDE TABLET (ORAL) PHENYTOIN SOD EXT CAPSULE (ORAL) A, HUSKY C, HUSKY D, Tuberculosis (TB) and Family CLINDAMYCIN PH 1% SOLUTION (not GEL or LOTION) (TOPICAL)IVERMECTIN TABLET (ORAL) PRIMIDONE (ORAL) Planning (FAMPL) clients. CLINDAMYCIN / BENZOYL PEROXIDE 1.2%-5% (DUAC) (TOPICAL) SABRIL 500 MG POWDER PACK (ORAL) • Preferred or Non-preferred status only applies to DIFFERIN 0.1% CREAM (TOPICAL) (not OTC GEL) (DX CODE REQ.) ANTI-ALLERGENS, ORAL SABRIL TABLET (ORAL) those medications that fall within the drug classes DIFFERIN
    [Show full text]
  • CORTISOL IMBALANCE Patient Handout
    COMMON PATTERNS OF CORTISOL IMBALANCE Patient HandOut Cortisol that does not follow the normal pattern can trigger blood sugar imbalances, food cravings and fat storage, especially around the middle. Related imbalances of low DHEA commonly result in loss of lean muscle, lack of strength, decreased stamina and low exercise tolerance. Chronically Elevated Cortisol Overall higher than normal cortisol Lifestyle suggestions: production throughout the day from • Reduce stress and improve coping skills prolonged stress demands. High • Protein at each meal, no skipping lunch cortisol also depletes its precursor hormone progesterone. • Hydrate throughout the day, herbal teas and water, avoid soft drinks General symptoms: • Reduce consumption of refined carbohydrates and caffeine • Food/sugar cravings • Get adequate sleep (at least 7 hours); catnaps • Feeling “tired but wired” • Aerobic exercise: <40 min low – moderate intensity • Insomnia during time when cortisol level within optimal range • Anxiety • Strength training: with guidance 2-3 times per week • Enjoy exercise that decreases excessive stress symptoms Steep Drop in Cortisol • Exercise in the morning Stress/fatigued pattern – morning Lifestyle suggestions: cortisol in the high normal range or • Reduce stress and improve coping skills elevated, but levels drop off rapidly, • Protein at each meal, no skipping lunch indicating adrenal dysfunction. • Hydrate throughout the day, herbal teas General symptoms: and water, avoid soft drinks • Mid-day energy drop • Reduce consumption of refined carbohydrates and caffeine • Drowsiness • Get adequate sleep (at least 7 hours); catnaps • Caffeine/sugar cravings • Exercise mid morning to boost energy with a combination • Low exercise tolerance/ of muscle building and cardiovascular activities poor recovery • Schedule more time for fun activities Rebound Cortisol Up and down/ irregular cortisol, Lifestyle suggestions: not following the normal pattern.
    [Show full text]
  • Sleep Deprivation on the Nighttime and Daytime Profile of Cortisol Levels
    Sleep. 20(10):865-870 © 1997 American Sleep Disorders Association and Sleep Research Society Sleep Loss Sleep Loss Results in an Elevation of Cortisol Levels the Next Evening Downloaded from https://academic.oup.com/sleep/article/20/10/865/2725962 by guest on 30 September 2021 *Rachel Leproult, tGeorges Copinschi, *Orfeu Buxton and *Eve Van Cauter *Department of Medicine, University of Chicago, Chicago, Illinois, U.S.A.; and tCenter for the Study of Biological Rhythms and Laboratory of Experimental Medicine, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium Summary: Sleep curtailment constitutes an increasingly common condition in industrialized societies and is thought to affect mood and performance rather than physiological functions. There is no evidence for prolonged or delayed effects of sleep loss on the hypothalamo-pituitary-adrenal (HPA) axis. We evaluated the effects of acute partial or total sleep deprivation on the nighttime and daytime profile of cortisol levels. Plasma cortisol profiles were determined during a 32-hour period (from 1800 hours on day I until 0200 hours on day 3) in normal young men submitted to three different protocols: normal sleep schedule (2300-0700 hours), partial sleep deprivation (0400-0800 hours), and total sleep deprivation. Alterations in cortisol levels could only be demonstrated in the evening following the night of sleep deprivation. After normal sleep, plasma cortisol levels over the 1800-2300- hour period were similar on days I and 2. After partial and total sleep deprivation. plasma cortisol levels over the 1800-2300-hour period were higher on day 2 than on day I (37 and 45% increases, p = 0.03 and 0.003, respec­ tively), and the onset of the quiescent period of cortisol secretion was delayed by at least I hour.
    [Show full text]
  • Hormonal and Metabolic Response to Operative Stress in the Neonate
    Hormonal and Metabolic Response to Operative Stress in the Neonate DAVID J. SCHMELING, M.D. AND ARNOLD G. CORAN, M.D. From the Section of Pediatric Surgery, Mott Children’s Hospital and University of Michigan Medical School, Ann Arbor, Michigan ABSTRACT. It is evident from this review that newborns, primarily catabolic in nature because the combined hormonal even those born prematurely, are capable of mounting an changes include an increased release of catabolic hormones endocrine and metabolic response to operative stress. Unfor- such as catecholamines, glucagon, and corticosteroids coupled tunately, many of the areas for which a relatively well-charac- with a suppression of and peripheral resistance to the effects terized response exists in adults are poorly documented in of the primary anabolic hormone, insulin. (Journal of Paren- neonates. As is the case in adults, the response seems to be teral and Enteral Nutrition 15:215-238, 1991) It is apparent that adult patients demonstrate a cata- are subjected to greatly increased rates of complications bolic response to the stresses induced by operative or such as cardiac or pulmonary insufficiency, myocardial accidental trauma. It seems that the degree of this cata- infarction, impaired hepatic and/or renal function, gas- bolic response may be quantitatively related to the extent tric stress ulcers, and sepsis. Furthermore, evidence ex- of the trauma or the magnitude of associated complica- ists to suggest that this response may be life threatening tions such as infection. The host response to infection, if the induced catabolic activity remains excessive or traumatic injury, or major operative stress is character- unchecked for a prolonged period.
    [Show full text]
  • Advice for Patients Who Take Replacement Steroids (Hydrocortisone, Prednisolone, Dexamethasone Or Plenadren) for Pituitary/Adrenal Insufficiency
    Advice for patients who take replacement steroids (hydrocortisone, prednisolone, dexamethasone or plenadren) for pituitary/adrenal insufficiency A number of you have been in touch looking for advice relating to the global coronavirus (also known as COVID-19) outbreak. If you are on steroid replacement therapy for pituitary or adrenal disease, or care for someone who is, and you’re worried about coronavirus, we’ve brought together a number of resources that we hope you will find useful. Coronavirus Adrenal Insufficiency Advice for Patients Primary adrenal insufficiency refers to all patients with loss of function of the adrenal itself, mostly either due to autoimmune Addison’s disease, or other causes such as congenital adrenal hyperplasia, bilateral adrenalectomy and adrenoleukodystrophy. The overwhelming majority of primary adrenal insufficiency patients suffer from both glucocorticoid and mineralocorticoid deficiency and usually take hydrocortisone (or prednisolone) and fludrocortisone. Our guidance similarly applies to patients with secondary adrenal insufficiency mostly due to pituitary tumours or previous high-dose glucocorticoid treatment. These patients take hydrocortisone for glucocorticoid deficiency As you will be aware it is important for patients with adrenal insufficiency to increase their steroids if unwell as per the usual sick day rules. Please ensure you have sufficient supplies to cover increased doses if you become unwell and an up to date emergency injection of hydrocortisone 100mg. Patients who suffer from a suspected or confirmed infection with coronavirus usually have high fever for many hours of the day, which results in the need for larger than usual steroid doses, so we advise slightly different sick day rules, which are listed below.
    [Show full text]